India to initiate Ayurvedic medicines against COVID-19

The Ayurvedic practitioners in India and the United States intend to conduct specific tests for Ayurvedan formulas against the latest coronavirus, the Indian envoy said. The news of Ayurveda is focused on Lalit K Jha Washington. On Wednesday, Indian Ambassador Taranjit Singh Sandhu told an emancipated group of American Indian scientists, academics and doctors that the large network of institutional commitments brought together the science groups of the two countries in their battle against COVID- 19. The Netherlands is the first to participate in this initiative.

The Ayurvedic practitioners and scientists in the two countries are preparing to launch joint clinical trials of Ayurvedic formulations against COVID-19, “said Sandhu.” This project will be under way through joint study and teachings programs and training programs for Ayurvedic. “The expertise and research tools in this field have been shared by our scientists,” he said. Indo-US Science Technology Forum (IUSSTF) has also been a part of joint programs supporting excellence in science , technology and innovation. The IUSSTF called for joint work and start-up efforts in order to tackle COVID-19 challenges. He has said that the experts on both sides are reviewing a large number of ideas in fast track mode.

“Indian pharmaceutical companies play an significant part in the fight against this pandemic and are the global market leaders in the development of affordable low-cost drugs and medical devices. As per the representative, there are at least three ongoing agreements with US-based institutions including Indian vaccine companies. These alliances will benefit not just India and the United States, but the billions that would need COVID-19 vaccinations throughout the world, he said.

He said technology firms and start-ups had already started to take the lead in this regard, believing that creativity would be the main catalyst for the pandemic response and management. “The telemedicine as well as telehealth markets are going to grow like other digital channels,” he said. He said scientists work together on a number of programs to understand key diseases at the basic level and clinical, noting that there has been a longstanding partnership between India and the US on the healthcare sector. Many of these projects concentrate on translation work to establish new therapeutics including diagnostic techniques.

More than 200 NIH-funded projects are underway in India involving 20 NIH-based institutions and other prominent Indian institutions associated with a wide variety of research fields to establish health solutions, said the senior diplomat. The Vaccine Action Program (VAP) partnership contributes to the creation of ROTAVAC rota virus vaccine, that causes extreme diarrhea in kids. The vaccine has been produced at an affordable price by an Indian company (Bharat Biotech). It was promoted and incorporated in the Extended Immunization Programme.

Many other vaccines, including tuberculosis, influenza and chikungunya are also being produced under VAP, he said. Sandhu said in his remarks: “As I speak, the VAP Meeting is underway where specialists from both countries are engaged closely in technical discussions in order to speed up the production of COVID-19 vaccine. The eminent experts praised India’s handling of the COVID-19 pandemic during the meeting and received useful recommendations and best practices. We expressed their thoughts about expanding the relationship among India and the United States.

Experts from a broad range of disciplines, including the fields of artificial intelligence, quantum technology, biomedical engineering, mechanical engineering, robotics, earth and oceans, virology, astronomy, astrophysics and safety sciions, engaged in contact. Speakers were Dr. Vijay Kuchroo, Samuel L, Professor of Neurology, Dr. Ashish M Kamat, Professor of Urology at the MD Anderson Cancer Center, Ashutosh Chilkoti, Alan L Kaganov Professor of Biomedical Engineering and Chair of the Biomedical Engin Department, amongst the participants in virtual engaging. Their research included Professors of Urology, OK Kak Regents, Dr. YOURSHIP IND AMS